Adagene
ADAG
25 hedge funds and large institutions have $9.7M invested in Adagene in 2026 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 3 closing their positions.
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
61% more capital invested
Capital invested by funds: $6.03M → $9.7M (+$3.67M)
47% more funds holding
Funds holding: 17 → 25 (+8)
0.45% more ownership
Funds ownership: 6.56% → 7% (+0.45%)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.76M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$136K |
| 3 |
PAP
Persistent Asset Partners
Hong Kong
|
+$102K |
| 4 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
+$101K |
| 5 |
Renaissance Technologies
New York
|
+$99.9K |
Top Sellers
| 1 |
EAM
Exome Asset Management
New York
|
-$936K |
| 2 |
FLC
Fifth Lane Capital
Austin,
Texas
|
-$274K |
| 3 |
KSCM
Kamunting Street Capital Management
Miami Beach,
Florida
|
-$255K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$91.4K |
| 5 |
Morgan Stanley
New York
|
-$27.5K |
ADAG Hedge Fund Activity: Q1 2026 in Review
25 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Adagene (ADAG) for Q1 2026, worth a combined $9.7M — up 61% from $6.03M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new ADAG positions and 3 closed out — a net gain of 8 holders — while 3 added to existing stakes and 6 trimmed.
The largest buyer was Ameriprise, opening a new position worth an estimated $1.76M. The largest seller was Exome Asset Management, cutting an estimated $936K.
- 25 institutional investors held Adagene (ADAG) as of Q1 2026, up from 17 in Q4 2025.
- Funds reported $9.7M of Adagene stock for Q1 2026, up 61% quarter-over-quarter.
- 11 funds opened new Adagene positions in Q1 2026 and 3 closed out, a net change of +8 holders.
- The largest Adagene buyer in Q1 2026 was Ameriprise, an estimated $1.76M added.
- The largest Adagene seller in Q1 2026 was Exome Asset Management, an estimated $936K sold.
Based on aggregated 13F filings for Q1 2026.